Status
Conditions
Treatments
About
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
Full description
The aims of this study are:
to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out);
to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction).
Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and
to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics).
Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Site Eligibility
OCP Participant Eligibility
Patient Eligibility
Patient under the care of a participating OCP as per self report;
English and/or Spanish speaking;
Is at least 18 years of age as per self report;
Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
Is a former or current smoking as per self report;
Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report
Exclusion criteria
Patient Exclusion
Site and OCP Exclusion
Primary purpose
Allocation
Interventional model
Masking
1,232 participants in 4 patient groups
Loading...
Central trial contact
Smita Banerjee, PhD; Jamie Ostroff, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal